---
title: "Medicalsystem's subsidiary has obtained multiple medical device registration certificates"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/257695997.md"
description: "Medicalsystem's holding subsidiary Jiangxi Meikang Shengde Biotechnology Co., Ltd. has obtained multiple medical device registration certificates issued by the Jiangxi Provincial Drug Administration. These registration certificates cover various in vitro diagnostic reagents, including tissue-type plasminogen activator - inhibitor 1 complex detection kit, thrombin - antithrombin complex detection kit, thrombomodulin detection kit, and plasmin-α2 plasmin inhibitor complex detection kit, all using chemiluminescent immunoassay"
datetime: "2025-09-17T09:48:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257695997.md)
  - [en](https://longbridge.com/en/news/257695997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257695997.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/257695997.md) | [English](https://longbridge.com/en/news/257695997.md)


# Medicalsystem's subsidiary has obtained multiple medical device registration certificates

According to the announcement from Medicalsystem (300439.SZ), the company's holding subsidiary Jiangxi Meikang Shengde Biotechnology Co., Ltd. (referred to as "Jiangxi Meikang") has obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagents)" issued by the Jiangxi Provincial Drug Administration. The products include: tissue-type plasminogen activator-inhibitor 1 complex detection kit (chemiluminescent immunoassay), thrombin-antithrombin complex detection kit (chemiluminescent immunoassay), thrombo-modulating protein detection kit (chemiluminescent immunoassay), plasmin-α2 plasmin inhibitor complex detection kit (chemiluminescent immunoassay)

### 相關股票

- [Medicalsystem (300439.CN)](https://longbridge.com/zh-HK/quote/300439.CN.md)

## 相關資訊與研究

- [10:00 ETSanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence](https://longbridge.com/zh-HK/news/281035304.md)
- [Ganfeng Lithium Turns to 2025 Profit](https://longbridge.com/zh-HK/news/281121946.md)
- [CATL's controlling shareholder to donate some A-shares](https://longbridge.com/zh-HK/news/281197776.md)
- [PetroChina Renews Financial Deal With Related Company](https://longbridge.com/zh-HK/news/280998322.md)
- [Ganfeng Lithium Swings Back to Profit on Higher Revenue in 2025](https://longbridge.com/zh-HK/news/281118530.md)